Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


What Statins Can’t Achieve: Failed AURORA Study Reinforces ESRD Doubts

Executive Summary

It was foregone that the AURORA trial testing rosuvastatin in patients with advanced kidney disease on dialysis didn't work out; AstraZeneca noted it would no longer pursue the project during its 2008 year-end earnings call Jan. 28

You may also be interested in...

FDA Panel Will Bring A SHARP Eye To Vytorin, Zetia sNDAs For Chronic Kidney Disease

The agency's Endocrinologic and Metabolic Drugs Advisory Committee will meet on Nov. 2 to discuss whether the SHARP study results support use of the cholesterol-lowering agents for cardiovascular risk reduction in patients with renal disease.

JUPITER Shines Celestial Glow On Statin Use; Docs Ready, But Are Payers?

A few months after the release of AstraZeneca's widely heralded JUPITER Crestor study, physicians seem prepared to prescribe statins more broadly based on that evidence, according to discussion at the American College of Cardiology annual meeting

Forest Files Memantine/Donepezil Fixed Combination For Alzheimer’s

Commercialization of the fixed-dose combo buys lifecycle management for Forest and should support future drug development for partner Adamas, the originator of the technology behind the combination.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts